Predictors of worsening renal function after computed tomography coronary angiography: Assessed by cystatin C

Journal of Cardiovascular Computed Tomography

Volumn 6, Issue 1, 2012, Pages 31-36

  Ando, Hirohiko ^a,b   Isobe, Satoshi ^a   Amano, Tetsuya ^b   Yamada, Takashi ^a   Ohtsubo, Hiroko ^a   Yuba, Miyuki ^b   Ishii, Hideki ^c   Murohara, Toyoaki ^c  

^a Kami iida Daiichi General Hospital   (Japan)

^b CHUBU ROSAI HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Computed tomography coronary angiography; Cystatin C; Diabetes; Oral fluid intake; Renal function

Indexed keywords

CHOLESTEROL; CREATININE; CYSTATIN C; GLUCOSE; HEMOGLOBIN A1C; IOPAMIDOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OYPALOMIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; FEMALE; FLUID INTAKE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; COMORBIDITY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYSTATIN C; FEMALE; HUMANS; IOPAMIDOL; JAPAN; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856218192     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2011.10.017     Document Type: Article

References (19)

1. Hamon M., Biondi-Zoccai G.G., Malagutti P., Agostoni P., Morello R., Valgimigli M., Hamon M. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol 2006, 48:1896-1910.
2. Stein P.D., Beemath A., Kayali F., Skaf E., Sanchez J., Olson R.E. Multidetector computed tomography for the diagnosis of coronary artery disease: a systematic review. Am J Med 2006, 119:203-216.
3. Mussap M., Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004, 41:467-550.
4. Levin A. Cystatin C, serum creatinine, and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk. Ann Intern Med 2005, 142:586-588.
5. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002, 40:221-226.
6. Perkins B.A., Nelson R.G., Ostrander B.E., Blouch K.L., Krolewski A.S., Myers B.D., Warram J.H. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005, 16:1404-1412.
7. Briguori C., Visconti G., Rivera N.V., Focaccio A., Golia B., Giannone R., Castaldo D., De Micco F., Ricciardelli B., Colombo A. Cystatin C andcontrast-induced acute kidney injury. Circulation 2010, 121:2117-2122.
8. Wu C.K., Lin J.W., Caffrey J.L., Chang M.H., Hwang J.J., Lin Y.S. Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J Am Coll Cardiol 2010, 56:1930-1936.
9. Isobe S., Sato K., Sugiura K., Mimura T., Kobayashi M., Meno C., Kato M., Ishii H., Murohara T. Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience. Circ J 2008, 72:1814-1820.
10. Kyhse-Andersen J., Schmidt C., Nordin G., Andersson B., Nilsson-Ehle P., Lindström V., Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994, 40:1921-1926.
11. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-983. Collaborators developing the Japanese equation for estimated GFR.
12. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
13. Weisberg L.S., Kurnik P.B., Kurnik B.R. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992, 41:1408-1415.
14. Prasad P.V., Priatna A., Spokes K., Epstein F.H. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 2001, 13:744-747.
15. Mueller C., Buerkle G., Buettner H.J., Petersen J., Perruchoud A.P., Eriksson U., Marsch S., Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002, 162:329-336.
16. Yoshikawa D., Isobe S., Sato K., Ohashi T., Fujiwara Y., Ohyama H., Ishii H., Murohara T. Importance of oral fluid intake after coronary computed tomography angiography: an observational study. Eur J Radiol 2011, 77:118-122.
17. Takeuchi T., Isobe S., Sato K., Kato I.M., Kasai N.N., Ohyama H., Yoshikawa D., Ishii H., Matsubara T., Murohara T. Cystatin C: a possible sensitive marker for detecting potential kidney injury after computed tomography coronary angiography. J Comput Assist Tomogr 2011, 35:240-245.
18. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., Pichard A.D., Kent K.M., Suddath W., Waksman Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003, 59:338-343.
19. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., Lansky A.J., Moussa I., Stone G.W., Moses J.W., Leon M.B., Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005, 95:13-19.